These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 24552476)
21. Effective long-term control of refractory hidradenitis suppurativa with adalimumab after failure of conventional therapy. Arenbergerova M; Gkalpakiotis S; Arenberger P Int J Dermatol; 2010 Dec; 49(12):1445-9. PubMed ID: 21091684 [TBL] [Abstract][Full Text] [Related]
22. Paradoxical psoriasiform reactions to antitumour necrosis factor-α drugs in hidradenitis suppurativa. Dequidt L; Cogrel O; Guillet S; Milpied B; Darrigade AS; Beylot-Barry M; Pham-Ledard A Br J Dermatol; 2018 Jan; 178(1):281-283. PubMed ID: 28444990 [No Abstract] [Full Text] [Related]
28. Observational case series on adalimumab-induced paradoxical hidradenitis suppurativa. Delobeau M; Abdou A; Puzenat E; Deveza E; Biver-Dalle C; van de Laak A; Roche-Kubler B; Vuitton L; Koch S; Wendling D; Aubin F J Dermatolog Treat; 2016; 27(3):251-3. PubMed ID: 26368546 [TBL] [Abstract][Full Text] [Related]
29. Interleukin 6 and high-sensitivity C-reactive protein are potential predictive markers of response to infliximab in hidradenitis suppurativa. Montaudié H; Seitz-Polski B; Cornille A; Benzaken S; Lacour JP; Passeron T J Am Acad Dermatol; 2017 Jan; 76(1):156-158. PubMed ID: 27986139 [No Abstract] [Full Text] [Related]
30. Successful control of hidradenitis suppurativa with verapamil: a case report. Laroche ML; Teste M; Vanoost J; Geniaux H Fundam Clin Pharmacol; 2019 Feb; 33(1):122-124. PubMed ID: 30025186 [TBL] [Abstract][Full Text] [Related]
31. Squamous cell carcinoma of the cervix arising in a patient on adalimumab � a need for cervical screenings in patients on tumor necrosis factor inhibitors. Bessaleli E; Scheinfeld N; Kroumpouzos- G Dermatol Online J; 2018 May; 24(5):. PubMed ID: 30142745 [TBL] [Abstract][Full Text] [Related]
32. Conversion to positive latent tuberculosis infection status is low in patients with hidradenitis suppurativa taking biologic medications. Ellis A; Khanna U; Galadari A; Fernandez AP J Am Acad Dermatol; 2020 Jul; 83(1):246-248. PubMed ID: 31940465 [No Abstract] [Full Text] [Related]
33. Clinical experience of the use of adalimumab in the management of hidradenitis suppurativa. Comparison of response rates with Crohn disease. Moyano B; Clemente A; Marín-Jiménez I; Martorell A Actas Dermosifiliogr; 2016 Sep; 107 Suppl 2():43-50. PubMed ID: 28081769 [TBL] [Abstract][Full Text] [Related]
34. Management of hidradenitis suppurativa with biological therapy: report of four cases and review of the literature. Bahillo Monné C; Honorato Guerra S; Schoendorff Ortega C; Gargallo Quintero AB Dermatology; 2014; 229(4):279-87. PubMed ID: 25472035 [TBL] [Abstract][Full Text] [Related]
35. Current and emerging nonsurgical treatment options for hidradenitis suppurativa. Kerdel FA Semin Cutan Med Surg; 2014 Jun; 33(3 Suppl):S57-9. PubMed ID: 25188460 [TBL] [Abstract][Full Text] [Related]
36. [Fatal pneumococcal sepsis in patient with hidradenitis suppurative treated with infliximab]. Benítez-Macías JF; García-Gil D; Brun-Romero FM Med Clin (Barc); 2008 Dec; 131(20):799. PubMed ID: 19094888 [No Abstract] [Full Text] [Related]
37. Golimumab for the Treatment of Hidradenitis Suppurativa in Patients with Previous TNF-α Treatment Failure. Melendez-Gonzalez MDM; Hamad J; Sayed C J Invest Dermatol; 2021 Dec; 141(12):2975-2979. PubMed ID: 34097922 [No Abstract] [Full Text] [Related]
38. Severe refractory hidradenitis suppurativa in an HIV-positive patient successfully treated with infliximab. Alecsandru D; Padilla B; Izquierdo JA; Fernández-Cruz E; Sánchez-Ramón S Arch Dermatol; 2010 Dec; 146(12):1343-5. PubMed ID: 21173317 [No Abstract] [Full Text] [Related]
39. Hidradenitis suppurativa managed with adalimumab. Yamauchi PS; Mau N J Drugs Dermatol; 2009 Feb; 8(2):181-3. PubMed ID: 19213236 [TBL] [Abstract][Full Text] [Related]
40. Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa. Kimball AB; Okun MM; Williams DA; Gottlieb AB; Papp KA; Zouboulis CC; Armstrong AW; Kerdel F; Gold MH; Forman SB; Korman NJ; Giamarellos-Bourboulis EJ; Crowley JJ; Lynde C; Reguiai Z; Prens EP; Alwawi E; Mostafa NM; Pinsky B; Sundaram M; Gu Y; Carlson DM; Jemec GB N Engl J Med; 2016 Aug; 375(5):422-34. PubMed ID: 27518661 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]